Nestle

Last updated January 31, 2026

125

Innovation Areas

3,230

Inventors

Collaborations

N-acetylspermidine and oligosaccharide bioactives: NestleRecent Research Landscape

Compromised epithelial integrity leads to systemic inflammation and dehydration risks. Specific ratios of 6′SL and LNT are engineered to fortify the gastrointestinal and transepidermal barriers.

What technical problems is Nestle addressing in N-acetylspermidine and oligosaccharide bioactives?

Impaired neonatal gastrointestinal development

(18)evidences

Imbalances in gut microbial populations lead to non-rotavirus diarrhea and systemic inflammation. Restoring homeostatic bacterial diversity prevents gastrointestinal failure modes and improves infant health outcomes.

Infant nociceptive hypersensitivity

(13)evidences

Suboptimal development of bone density and compromised epithelial barriers in the gut and skin lead to systemic vulnerability. Addressing these structural deficiencies prevents chronic developmental delays and environmental sensitivity.